Human IL-27 Human IL-27 ELISA Kit

Key features and details

  • Specification: 96 Test
  • Sensitivity: 3.22 pg/ml (50 μl);4.45 pg/ml (10 μl)
  • Standard Curve Range: 4.10~1000 pg/ml
  • Standard Curve Gradient: 7 Points
  • Number of Incubations: 2
  • Sample Volume: 50 μl/10 μl
  • Assay type: Sandwich Elisa
  • Operation Duration: 120min
  • Brand:
CAT.NO. : AEH0094
RMB Please choose
RMB Please choose
Size:
96T
Trail, Bulk size or Custom requests Please contact us
*产品价格可能会有所调整,请以品牌方官网实时更新的价格为准,以确保准确性。
Product Details
Background
IL-27 is a heterodimeric group 2 receptor ligand molecule that belongs to the IL-6/IL-12 family of long type I cytokines. It is composed of EBI3 (EBV-induced gene 3), a 34 kDa glycoprotein that is related to the p40 subunit of IL-12 and IL-23, and p28, the 28 kDa glycoprotein that is related to the p35 chain of IL-12. The human EBI3 gene encodes a 229 amino acid (aa) precursor that contains a 20 aa signal peptide and 209 aa mature protein. The mature region contains two potential N-linked glycosylation sites, two fibronectin type III domains, and two pairs of conserved cysteine residues with a WSXWS-like motif that places the molecule in the hematopoietin receptor family. Although p40, the EBI3 counterpart in IL-12, is known to form homodimers, there is no evidence to date that EBI3 also homodimerizes. Human EBI3 is 61% aa identical to mouse EBI3. The human p28 gene encodes a 243 aa precursor that contains a 28 aa signal sequence and 215 aa mature region. The mature region is characterized by the presence of four alpha -helices, placing it in the IL-6 family of helical cytokines. Human p28 is 74% aa identical to mouse p28. IL-27 is expressed by monocytes, endothelial cells and dendritic cells. IL-27 binds to and signals through a heterodimeric receptor complex composed of WSX-1 (TCCR) and gp130. Evidence suggests IL-27 interacts only with WSX-1. IL-27 has both anti- and proinflammatory properties. As an anti-inflammatory, IL-27 seems to induce a general negative feedback program that limits T and NK-T cell activity. At the onset of infection, IL-27 induces an IL-12 receptor on naïve CD4+ T cells, making them susceptible to subsequent IL-12 activity (and possible Th1 development).
Typical Data


pg/ml

O.D.

Average

Corrected

0.00

0.0348

0.0396

0.0372

13.72

0.0476

0.0455

0.0466

0.0094

41.15

0.0701

0.0681

0.0691

0.0319

123.46

0.1287

0.1349

0.1318

0.0946

370.37

0.3138

0.3228

0.3183

0.2811

1111.11

0.8036

0.8394

0.8215

0.7843

3333.33

2.1080

2.1650

2.1365

2.0993

10000.00

4.1420

4.2020

4.1720

4.1348

Precision

Intra-assay Precision

Inter-assay Precision

Sample Number

S1

S2

S3

S1

S2

S3

22

22

22

6

6

6

Average(pg/ml)

205.1

1064.4

3596.5

203.0

1017.0

3373.2

Standard Deviation

5.0

35.7

123.5

11.8

29.4

104.1

Coefficient of Variation(%)

2.4

3.4

3.4

5.8

2.9

3.1


Intra-assay Precision (Precision within an assay) Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.

Inter-assay Precision (Precision between assays)  Three samples of known concentration were tested six times on one plate to assess intra-assay precision.

Spike Recovery
The spike recovery was evaluated by spiking 3 levels of human IL-27 into health human serum sample. The un-spiked serum was used as blank in this experiment.
The recovery ranged from 80% to 102% with an overall mean recovery of 91%.
Sample Values

Sample

Matrix

Sample 

Evaluated

Range

(ng/ml)

Detectable

%

Mean of Detectable

(ng/ml)

Serum

30

n.d.-405.59 75 68.41


Serum/Plasma – Thirty samples from apparently healthy volunteers were evaluated for the presence of IL-12/IL-23 p40 in this assay. No medical histories were available for the donors.
New Products
Get in touch with AREX
Name:*
Tel/Phone:*
Company:*
Email:*
Inquiry:
Captcha*
Submitting your email information means that you are willing to receive email information from AREX regarding technology, applications, products, and events. By clicking on the 'unsubscribe' button in the email or by contacting info@arexbio.com You can unsubscribe at any time by sending an email. Regarding your data usage information, please refer to our privacy policy.
© AREX 2024. All Rights Reserved. | 浙ICP备2024113709号-3 Sitemap